The two hit hypothesis: An improved method for siRNA-mediated gene silencing in stimulated primary human T cells

Journal of Immunological Methods

Volumn 396, Issue 1-2, 2013, Pages 116-127

  Freeley, Michael ^a   Long, Aideen ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Gene silencing; Nucleofection; SiRNA; T cell; Transfection

Indexed keywords

CHEMOKINE; PROTEIN KINASE C BETA; SMALL INTERFERING RNA; TALIN;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROPORATION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NUCLEOFECTION; PLASMID; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

GENE SILENCING; NUCLEOFECTION; SIRNA; T CELL; TRANSFECTION;

CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ELECTROPORATION; GENE EXPRESSION; HUMANS; LYMPHOCYTE ACTIVATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; T-LYMPHOCYTES; TRANSFECTION;

EID: 84884350676     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.08.005     Document Type: Article

References (40)

1. Aagaard L., Rossi J.J. RNAi therapeutics: principles, prospects and challenges. Adv. Drug Deliv. Rev. 2007, 59:75-86.
2. Amarnath S., Mangus C.W., Wang J.C., Wei F., He A., Kapoor V., Foley J.E., Massey P.R., Felizardo T.C., Riley J.L., Levine B.L., June C.H., Medin J.A., Fowler D.H. The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci. Transl. Med. 2011, 3:111ra120.
3. Baldauf H.M., Pan X., Erikson E., Schmidt S., Daddacha W., Burggraf M., Schenkova K., Ambiel I., Wabnitz G., Gramberg T., Panitz S., Flory E., Landau N.R., Sertel S., Rutsch F., Lasitschka F., Kim B., Konig R., Fackler O.T., Keppler O.T. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat. Med. 2012, 18:1682-1687.
4. Bradley L.M. Migration and T-lymphocyte effector function. Curr. Opin. Immunol. 2003, 15:343-348.
5. Budhiraja S., Ramakrishnan R., Rice A.P. Phosphatase PPM1A negatively regulates P-TEFb function in resting CD4T+ T cells and inhibits HIV-1 gene expression. Retrovirology 2012, 9:52.
6. Chehtane M., Khaled A.R. Interleukin-7 mediates glucose utilization in lymphocytes through transcriptional regulation of the hexokinase II gene. Am. J. Physiol. Cell Physiol. 2010, 298:C1560-C1571.
7. Cohen P. Guidelines for the effective use of chemical inhibitors of protein function to understand their roles in cell regulation. Biochem. J. 2010, 425:53-54.
8. Eguchi A., Dowdy S.F. siRNA delivery using peptide transduction domains. Trends Pharmacol. Sci. 2009, 30:341-345.
9. 2 pathway. PLoS Pathog. 2010, 6:e1000975.
10. Freeley M., O'Dowd F., Paul T., Kashanin D., Davies A., Kelleher D., Long A. L-plastin regulates polarization and migration in chemokine-stimulated human T lymphocytes. J. Immunol. 2012, 188:6357-6370.
11. Gehl J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol. Scand. 2003, 177:437-447.
12. Ghoreschi K., Laurence A., O'Shea J.J. Selectivity and therapeutic inhibition of kinases: to be or not to be?. Nat. Immunol. 2009, 10:356-360.
13. Goffinet C., Keppler O.T. Efficient nonviral gene delivery into primary lymphocytes from rats and mice. FASEB J. 2006, 20:500-502.
14. Gresch O., Engel F.B., Nesic D., Tran T.T., England H.M., Hickman E.S., Korner I., Gan L., Chen S., Castro-Obregon S., Hammermann R., Wolf J., Muller-Hartmann H., Nix M., Siebenkotten G., Kraus G., Lun K. New non-viral method for gene transfer into primary cells. Methods 2004, 33:151-163.
15. Haan C., Behrmann I. A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background. J. Immunol. Methods 2007, 318:11-19.
16. Hinterleitner R., Gruber T., Pfeifhofer-Obermair C., Lutz-Nicoladoni C., Tzankov A., Schuster M., Penninger J.M., Loibner H., Lametschwandtner G., Wolf D., Baier G. Adoptive transfer of siRNA Cblb-silenced CD8(+) T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model. PLoS One 2012, 7:e44295.
17. Hurez V., Hautton R.D., Oliver J., Matthews R.J., Weaver C.K. Gene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction. Immunol. Res. 2002, 26:131-141.
18. June C.H., Blazar B.R., Riley J.L. Engineering lymphocyte subsets: tools, trials and tribulations. Nat. Rev. Immunol. 2009, 9:704-716.
19. Kumar P., Ban H.S., Kim S.S., Wu H., Pearson T., Greiner D.L., Laouar A., Yao J., Haridas V., Habiro K., Yang Y.G., Jeong J.H., Lee K.Y., Kim Y.H., Kim S.W., Peipp M., Fey G.H., Manjunath N., Shultz L.D., Lee S.K., Shankar P. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 2008, 134:577-586.
20. Lefort C.T., Kim M. Human T Lymphocyte Isolation, Culture and Analysis of Migration In Vitro. J. Vis. Exp. 2010, (40):e2017. 10.3791/2017.
21. Li F.Y., Chaigne-Delalande B., Kanellopoulou C., Davis J.C., Matthews H.F., Douek D.C., Cohen J.I., Uzel G., Su H.C., Lenardo M.J. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature 2011, 475:471-476.
22. Liu Z., Winters M., Holodniy M., Dai H. siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew. Chem. Int. Ed. Engl. 2007, 46:2023-2027.
23. Mantei A., Rutz S., Janke M., Kirchhoff D., Jung U., Patzel V., Vogel U., Rudel T., Andreou I., Weber M., Scheffold A. siRNA stabilization prolongs gene knockdown in primary T lymphocytes. Eur. J. Immunol. 2008, 38:2616-2625.
24. Morin N.A., Oakes P.W., Hyun Y.M., Lee D., Chin Y.E., King M.R., Springer T.A., Shimaoka M., Tang J.X., Reichner J.S., Kim M. Nonmuscle myosin heavy chain IIA mediates integrin LFA-1 de-adhesion during T lymphocyte migration. J. Exp. Med. 2008, 205:195-205.
25. Moriwaki A., Inoue H., Nakano T., Matsunaga Y., Matsuno Y., Matsumoto T., Fukuyama S., Kan O.K., Matsumoto K., Tsuda-Eguchi M., Nagakubo D., Yoshie O., Yoshimura A., Kubo M., Nakanishi Y. T cell treatment with small interfering RNA for suppressor of cytokine signaling 3 modulates allergic airway responses in a murine model of asthma. Am. J. Respir. Cell Mol. Biol. 2011, 44:448-455.
26. Neff C.P., Zhou J., Remling L., Kuruvilla J., Zhang J., Li H., Smith D.D., Swiderski P., Rossi J.J., Akkina R. An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice. Sci. Transl. Med. 2011, 3:66ra6.
27. Peer D., Shimaoka M. Systemic siRNA delivery to leukocyte-implicated diseases. Cell Cycle 2009, 8:853-859.
28. Peer D., Park E.J., Morishita Y., Carman C.V., Shimaoka M. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science 2008, 319:627-630.
29. Perlmutter R.M., Alberola-Ila J. The use of dominant-negative mutations to elucidate signal transduction pathways in lymphocytes. Curr. Opin. Immunol. 1996, 8:285-290.
30. Rabinovich P.M., Komarovskaya M.E., Ye Z.J., Imai C., Campana D., Bahceci E., Weissman S.M. Synthetic messenger RNA as a tool for gene therapy. Hum. Gene Ther. 2006, 17:1027-1035.
31. Restifo N.P., Dudley M.E., Rosenberg S.A. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat. Rev. Immunol. 2012, 12:269-281.
32. Saveliev A., Tybulewicz V.L. Lymphocyte signaling: beyond knockouts. Nat. Immunol. 2009, 10:361-364.
33. Singh S., Narang A.S., Mahato R.I. Subcellular fate and off-target effects of siRNA, shRNA, and miRNA. Pharm. Res. 2011, 28:2996-3015.
34. Smith L.D., Hickman E.S., Parry R.V., Westwick J., Ward S.G. PI3Kgamma is the dominant isoform involved in migratory responses of human T lymphocytes: effects of ex vivo maintenance and limitations of non-viral delivery of siRNA. Cell. Signal. 2007, 19:2528-2539.
35. Song J., Lei F.T., Xiong X., Haque R. Intracellular signals of T cell costimulation. Cell. Mol. Immunol. 2008, 5:239-247.
36. Steward-Tharp S.M., Song Y.J., Siegel R.M., O'Shea J.J. New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression. Ann. N. Y. Acad. Sci. 2010, 1183:123-148.
37. Tahvanainen J., Pykalainen M., Kallonen T., Lahteenmaki H., Rasool O., Lahesmaa R. Enrichment of nucleofected primary human CD4+ T cells: a novel and efficient method for studying gene function and role in human primary T helper cell differentiation. J. Immunol. Methods 2006, 310:30-39.
38. Thelen M., Stein J.V. How chemokines invite leukocytes to dance. Nat. Immunol. 2008, 9:953-959.
39. Wabnitz G.H., Lohneis P., Kirchgessner H., Jahraus B., Gottwald S., Konstandin M., Klemke M., Samstag Y. Sustained LFA-1 cluster formation in the immune synapse requires the combined activities of L-plastin and calmodulin. Eur. J. Immunol. 2010, 40:2437-2449.
40. Zhou J., Neff C.P., Liu X., Zhang J., Li H., Smith D.D., Swiderski P., Aboellail T., Huang Y., Du Q., Liang Z., Peng L., Akkina R., Rossi J.J. Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice. Mol. Ther. 2011, 19:2228-2238.